Neurological Adverse Effects of Antipsychotic Medication in Children and Young People

Frank M C Besag1,2,3, Michael J Vasey4, Chris Hollis5,6,7

  • 1East London NHS Foundation Trust, 9 Rush Court, Bedford, MK40 3JT, UK. fbesag@aol.com.

Paediatric Drugs
|January 7, 2026
PubMed

Insights

Children and young people (CYP) taking antipsychotics face neurological adverse effects (NAEs), including sedation and movement disorders. More research is needed to understand NAE risks and management in this vulnerable population.

Area of Science:

  • Pharmacology
  • Pediatric Neurology
  • Psychiatry

Background:

  • Neurological adverse effects (NAEs) are a significant concern in patients using antipsychotic medications.
  • Children and young people (CYP) may exhibit increased susceptibility to NAEs, yet research specific to this demographic is limited.

Purpose of the Study:

  • To review the existing literature on NAEs in CYP, focusing on data from randomized placebo-controlled trials.
  • To highlight the prevalence, types, and potential risk factors of NAEs in pediatric populations undergoing antipsychotic treatment.

Main Methods:

  • Systematic review of published literature on NAEs in CYP.
  • Emphasis on data derived from randomized placebo-controlled trials.
  • Analysis of reported NAEs including sedation, movement disorders, seizure threshold changes, and neuroleptic malignant syndrome.

Main Results:

  • Sedative effects and movement disorders like akathisia, dystonia, and parkinsonism are common in CYP, though often show minimal changes in short-term studies.
  • Tardive dyskinesia seems less frequent in CYP than adults, but data is scarce.
  • Antipsychotics like clozapine may lower seizure threshold, with unclear vulnerability in CYP; neuroleptic malignant syndrome is rare but serious.

Conclusions:

  • Current data on NAEs in CYP is limited, with many risk factors and management strategies extrapolated from adult studies.
  • Further research, particularly self-controlled studies using large prospective databases, is crucial to clarify NAE incidence and risk factors in CYP.
  • There is a need for evidence-based guidelines tailored to the pediatric population regarding antipsychotic-induced NAEs.

Related Concept Videos

Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
735
Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
744
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
802
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.9K